Back

Dynamic changes in liver fibrosis and the risk of death and bleeding in non-cirrhotic patients with atrial fibrillation treated with NOACs.

28 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: phenotyping and risk prediction Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tommaso Bucci

University of Perugia, Perugia (Italy)

6 More presentations in this session

Presentation thumbnail
Deep learning-based detection of paroxysmal atrial fibrillation from sinus rhythm electrocardiograms and its association with stroke risk
Doctor Y. Na (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Untargeted-metabolomics identifies key metabolites for atrial fibrosis and recurrence of atrial fibrillation indication across populations
Doctor M. Chu (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Identification of new atrial fibrillation phenotypes from insertable cardiac monitor recordings using unsupervised machine learning
Doctor E. Flo Lenz (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
The prognostic value of sinus rhythm restoration in patients hospitalized for atrial fibrillation
Doctor A. Samaras (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Head-to-head comparison of CHADS₂, CHA₂DS₂-VASc, CHA₂DS₂-VA, HAS-BLED, and HELT-E₂S₂ scores in edoxaban treated atrial fibrillation patients: a 2-year analysis from the ETNA-AF Global program
Doctor C. Wang (Taipei, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: phenotyping and risk prediction

The Event

Event poster

ESC Congress 2026

28 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Bleeding risk profile and heart failure hospitalizations in patients with atrial fibrillation according to FIB-4 index
26 August 2023
thumbnail
Congress Presentation
Real world data on left atrial appendage closure after severe bleeding in anticoagulated patients with atrial fibrillation: frequency and associated factors.
29 August 2025
thumbnail
Congress Presentation
Clinical outcomes following atrial fibrillation diagnosis in routine practice: a nationwide cohort study in Sweden
28 August 2026
thumbnail
Congress Presentation
Safety and efficacy of anticoagulation for atrial fibrillation in cirrhotic patients
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources